PPARγ2 Pro12Ala polymorphism analysis

Exploratory Score: 0.800 Price: $0.50 diabetes human genetic variant analysis Status: proposed

What This Experiment Tests

Exploratory experiment designed to discover new patterns targeting PPARγ2 in human genetic variant analysis. Primary outcome: TUG binding affinity to PPARγ2 variants

Description

Analysis of the PPARγ2 Pro12Ala polymorphism, which is known to reduce diabetes risk, and its relationship to TUG binding. The study examined how this specific amino acid change affects the interaction between TUG cleavage products and PPARγ2. Researchers investigated whether the protective Pro12Ala variant enhances TUG binding compared to the wild-type sequence, potentially explaining part of its protective effect against diabetes through enhanced insulin sensitivity and metabolic function.

TARGET GENE
PPARγ2
MODEL SYSTEM
human genetic variant analysis
ESTIMATED COST
$0
TIMELINE
0 months
PATHWAY
PPARγ signaling pathway
SOURCE
extracted_from_pmid_33686286
PRIMARY OUTCOME
TUG binding affinity to PPARγ2 variants

Scoring Dimensions

Info Gain 0.00 (25%) Feasibility 0.00 (20%) Hyp Coverage 0.00 (20%) Cost Effect. 0.00 (15%) Novelty 0.00 (10%) Ethical Safety 0.00 (10%) 0.800 composite

📖 Wiki Pages

Researchersindex

Protocol

Protein binding assays, functional studies with variant proteins, interaction measurements

Expected Outcomes

Enhanced TUG binding to Pro12Ala variant compared to wild-type PPARγ2

Success Criteria

Measurably increased binding affinity for the protective polymorphic variant

Related Hypotheses (0)

No related hypotheses

Debate History (0)

No debates yet

Experiment Results (0)

No results recorded yet. Use POST /api/experiments/{id}/results to record a result.